{"slideshow_credits": null, "snippet": "A private equity firm is fined for misleading investors, a once-promising relationship goes sour, and a controversial pharmaceuticals company is back in the headlines....", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Amie", "role": "reported", "lastname": "TSANG", "rank": 1, "organization": ""}], "original": "By AMIE TSANG"}, "web_url": "http://www.nytimes.com/2016/08/24/business/dealbook/apollo-sec-turing-lawsuit-shkreli.html", "lead_paragraph": "A private equity firm is fined for misleading investors, a once-promising relationship goes sour, and a controversial pharmaceuticals company is back in the headlines.", "headline": {"main": "Morning Agenda: Fining Apollo, When Deals Go Sour, and Controversy at Turing"}, "_id": "57bd70d595d0e021d79824af", "word_count": "541", "multimedia": [{"height": 126, "url": "images/2016/08/24/business/24db-newsletter/24db-newsletter-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/08/24/business/24db-newsletter/24db-newsletter-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2016/08/24/business/24db-newsletter/24db-newsletter-articleLarge.jpg", "legacy": {"xlarge": "images/2016/08/24/business/24db-newsletter/24db-newsletter-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/08/24/business/24db-newsletter/24db-newsletter-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/08/24/business/24db-newsletter/24db-newsletter-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-08-24T04:00:00+0000", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Private Equity", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Ethics and Official Misconduct", "is_major": "N", "rank": "4"}, {"name": "persons", "value": "Shkreli, Martin (1983- )", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Apollo Global Management", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "LyondellBasell", "is_major": "N", "rank": "7"}, {"name": "organizations", "value": "Securities and Exchange Commission", "is_major": "N", "rank": "8"}, {"name": "organizations", "value": "Turing Pharmaceuticals AG", "is_major": "N", "rank": "9"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}